Voyager Acquisition(VACH.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Voyager Acquisition
VACH.US
Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors.
1.236 T
VACH.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Global computer vision in healthcare market to grow by $10.97 billion by 2030 with a CAGR of 31.1%. Report covers market trends and vendor analysis.

    A recent market report on Computer Vision in Healthcare forecasts significant growth, with the global market expected to increase by USD 10.97 billion from 2025 to 2030. The market is projected to experience a remarkable Compound Annual Growth Rate (CAGR) of 31.1% during this period. The report offers a thorough analysis of the market, encompassing size, future projections, trends, factors driving growth, challenges, and an extensive vendor analysis of around 25 key players.

    Unusual Whales·
    Unusual Whales·

    17:30 ET $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRTAF, LCTC, VACH, and EFIN

    Class Action Attorney Juan Monteverde of Monteverde & Associates PC is investigating mergers involving Cartica Acquisition Corp. (CRTAF), Lifeloc Technologies, Inc. (LCTC), Voyager Acquisition Corp. (VACH), and Eastern Michigan Financial Corporation (EFIN). The firm has a successful track record in recovering funds for shareholders and is recognized in the 2024 ISS Securities Class Action Services Report. The investigations focus on the terms of the proposed mergers, which involve significant equity values and share conversions. Shareholders with concerns can contact the firm for more information.

    prnewswire·
    US
    CITEU
    0.00%
    US
    VACH
    -0.09%
    prnewswire·
    US
    CITEU
    0.00%
    US
    VACH
    -0.09%

    Voyager Acquisition Corp. Extends Veraxa Deal Deadline and Removes Termination Fee

    Voyager Acquisition Corp. has amended its business combination agreement with Veraxa Biotech AG, extending the deadline to August 7, 2026. The amendment also eliminates the termination fee requirement for Voyager if the agreement is terminated under specific conditions. This information was disclosed in a recent company filing.

    Reuters·
    US
    VACH
    -0.09%
    Reuters·
    US
    VACH
    -0.09%

    $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Voyager Acquisition Corp. ( NASDAQ: VACH )

    Class Action Attorney Juan Monteverde of Monteverde & Associates PC is investigating Voyager Acquisition Corp. (NASDAQ: VACH) regarding its merger with Veraxa Biotech AG. The investigation focuses on whether the deal, which involves the cancellation of Voyager's Class A and B shares in exchange for shares in the combined company, is fair to shareholders. The firm has a strong track record in recovering funds for shareholders and offers free consultations for those concerned about the merger.

    Benzinga·
    US
    VACH
    -0.09%
    Benzinga·
    US
    VACH
    -0.09%

    VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC | VACH Stock News

    VERAXA Biotech AG and Voyager Acquisition Corp. have filed a Form F-4 Registration Statement with the SEC regarding their proposed Business Combination Agreement. This marks a significant step for VERAXA towards becoming a public company, with an equity value contribution of approximately $1.3 billion. Upon closing, VERAXA is expected to access up to $253 million in cash held in trust by Voyager. The transaction is anticipated to close in Q4 2025, subject to shareholder approval and customary closing conditions.

    StockTitan·
    US
    VACH
    -0.09%
    StockTitan·
    US
    VACH
    -0.09%
    © 2026 Longbridge｜Disclaimer